These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1994947)

  • 1. Accuracy of common drug screen tests.
    Schwartz JG; Zollars PR; Okorodudu AO; Carnahan JJ; Wallace JE; Briggs JE
    Am J Emerg Med; 1991 Mar; 9(2):166-70. PubMed ID: 1994947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency department evaluation of a rapid assay for detection of cocaine metabolites in urine specimens.
    Belfer RA; Klein BL; Boenning DA; Soldin SJ
    Pediatr Emerg Care; 1996 Apr; 12(2):113-5. PubMed ID: 8859922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for drugs of abuse with the Roche ONTRAK assays.
    Armbruster DA; Krolak JM
    J Anal Toxicol; 1992; 16(3):172-5. PubMed ID: 1522711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA; Schwarzhoff RH; Hubster EC; Liserio MK
    Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of ONTRAK TESTCUP, abuscreen ONTRAK, abuscreen ONLINE, and GC/MS urinalysis test results.
    Crouch DJ; Cheever ML; Andrenyak DM; Kuntz DJ; Loughmiller DL
    J Forensic Sci; 1998 Jan; 43(1):35-40. PubMed ID: 9456522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results.
    Huestis MA; Mitchell JM; Cone EJ
    Clin Chem; 1994 May; 40(5):729-33. PubMed ID: 8174244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of TDx cocaine metabolite assay.
    Poklis A
    J Anal Toxicol; 1987; 11(5):228-30. PubMed ID: 3682784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the EZ-SCREEN enzyme immunoassay test for detection of cocaine and marijuana metabolites in urine specimens.
    Schwartz RH; Bogema S; Thorne MM
    Pediatr Emerg Care; 1990 Jun; 6(2):147-9. PubMed ID: 2196539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
    Peace MR; Poklis JL; Tarnai LD; Poklis A
    J Anal Toxicol; 2002 Oct; 26(7):500-3. PubMed ID: 12423007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs.
    Towt J; Tsai SC; Hernandez MR; Klimov AD; Kravec CV; Rouse SL; Subuhi HS; Twarowska B; Salamone SJ
    J Anal Toxicol; 1995 Oct; 19(6):504-10. PubMed ID: 8926746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The screening for common drugs of abuse in whole blood by means of EMIT-ETS and FPIA-ADx urine immunoassays.
    Maier RD; Erkens M; Hoenen H; Bogusz M
    Int J Legal Med; 1992; 105(2):115-9. PubMed ID: 1520635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the OnTrak Testcup-5 to laboratory urinalysis among arrestees.
    Yacoubian GS; Wish ED; Choyka JD
    J Psychoactive Drugs; 2002; 34(3):325-9. PubMed ID: 12422945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
    Przekop MA; Manno JE; Kunsman GW; Cockerham KR; Manno BR
    J Anal Toxicol; 1991; 15(6):323-6. PubMed ID: 1779660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.